Ibujerry Plus Oral Suspension Orange

Paracetamol acts centrally to inhibit prostaglandin synthesis, providing effective analgesic and antipyretic effects without significant anti-inflammatory action. The orange-flavored oral suspension formulation facilitates ease of administration, particularly in pediatric and geriatric populations. Ibujerry Plus should be used according to the recommended dosage to minimize the risk of adverse effects such as gastrointestinal irritation, hepatotoxicity, or hypersensitivity reactions.

It is contraindicated in patients with known hypersensitivity to ibuprofen, paracetamol, or any excipients, as well as those with active gastrointestinal bleeding or severe hepatic impairment. Caution is advised in individuals with renal dysfunction, asthma, or cardiovascular disease. Consultation with a healthcare professional is recommended before use, especially in children under 12 years, pregnant or breastfeeding women, and patients on concurrent medications to avoid potential drug interactions.